Evaluation of Pertuzumab-Trastuzumab and Taxane in the Standard Treatment of Metastatic Breast Cancer

NCT03979911 · clinicaltrials.gov ↗

UNKNOWN

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms
HER-2 Gene Amplification

Sponsor

University Hospital, Brest